Proud For Profits
  • Investing
  • Stock
  • Latest News
  • Economy
  • Investing
  • Stock
  • Latest News
  • Economy
No Result
View All Result
Proud For Profits
No Result
View All Result
Home Stock

Chinese stocks hold bullish outlook, Gavekal Research says

by
September 24, 2024
in Stock
0
Chinese stocks hold bullish outlook, Gavekal Research says

Investing.com– Chinese stocks are primed for a rebound in the coming months, Gavekal Research said in a note, stating that they were undervalued after prolonged underperformance, and that Beijing was likely to unveil more stimulus measures. 

In a note dated to Monday, Gavekal said they were “very bullish” on Chinese equities, and advocated staying long on the market. They recommended getting into Chinese stocks before the beginning of the next bull run.

The Gavekal note came just a day before China rolled out a barrage of stimulus measures, including a cut to bank reserve requirements, lower mortgage rates and potential liquidity support for local stocks. The moves saw China’s Shanghai Shenzhen CSI 300 and Shanghai Composite indexes rally over 2% each from near eight-month lows, while Hong Kong’s Hang Seng index surged over 3%. 

Gavekal said the Chinese market was undervalued in comparison to gold, and that dividend yields on Chinese stocks were higher than the government bond yield. Such a scenario had occurred only twice in the past, and the Chinese market had rallied exponentially both times. 

Gavekal said that persistent underperformance in the stock market was likely to elicit more stimulus measures from the government- with the government potentially cutting taxes for local firms. 

Chinese stocks are by far the worst performers in Asia over the past two years, as a sustained deflationary trend in the country and a protracted property market decline saw investors largely pull out of local markets. 

But this has pushed the view that several notable Chinese names, especially the country’s biggest internet firms, are trading at attractive discounts.

This post appeared first on investing.com
Previous Post

Levi Strauss warns of delay in hitting $10 billion sales goal, FT reports

Next Post

Pro Research: Wall Street dives into Amgen’s diverse biopharma strategies

Next Post
Pro Research: Wall Street dives into Amgen’s diverse biopharma strategies

Pro Research: Wall Street dives into Amgen’s diverse biopharma strategies

Enter Your Information Below To Receive Trading Ideas and Latest News

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Popular News

    Trump rolls out plan to back farmers amid rising costs, pledging ‘golden age’

    Trump rolls out plan to back farmers amid rising costs, pledging ‘golden age’

    March 28, 2026
    Trump signs executive order ensuring TSA workers are paid during DHS shutdown

    Trump signs executive order ensuring TSA workers are paid during DHS shutdown

    March 28, 2026
    Rubio meets G7 ministers in France as US leads on Iran — allies under fire for tepid response

    Rubio meets G7 ministers in France as US leads on Iran — allies under fire for tepid response

    March 27, 2026
    Track all markets on TradingView

    About Proud For Profits

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Main Categories

    • Investing
    • Stock
    • Latest News
    • Economy

    Latest News

    • Trump rolls out plan to back farmers amid rising costs, pledging ‘golden age’
    • Trump signs executive order ensuring TSA workers are paid during DHS shutdown
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 proudforprofits.com | All Rights Reserved

    No Result
    View All Result
    • Investing
    • Stock
    • Latest News
    • Economy

    Copyright © 2026 proudforprofits.com | All Rights Reserved